Scholars Central

Research articlePublished 6 Jun 2005

Topical Administration of Caroverine in Somatic Tinnitus Treatment: Proof-of-Concept Study

Authors: Klaus Ehrenberger

The International Tinnitus Journal

Volume 11 · Issue 1 · Pages 34–37

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This prospective study, which conformed with good clinical practice (GCPconform), tested the concept that the topical transtympanic administration of the quinoxaline derivative Caroverine promises a new approach to the treatment of tinnitus. The rationale for the study is the hypothesis that tinnitus reflects sequelae of auditory neurotoxicity that can prevented and repaired by the neuroprotective and neuroregenerative activities of quinoxaline derivatives exhibited in previous preclinical tests. In a representative patient cohort, the probability of a long-lasting tinnitolytic effect of lipophilic eardrops containing 1 % Caroverine as their active ingredient gained in significance, crossing from low-intensity levels to high-intensity levels of individual tinnitus sensations. These results encouraged us to design consequential GCP-conform phase 2 and phase 3 studies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in The International Tinnitus Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalThe International Tinnitus Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Klaus Ehrenberger”